Transcription of For injection: 100 mg of lyophilized infliximab-abda …
{{id}} {{{paragraph}}}
1 HIGHLIGHTS OF prescribing information These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information for RENFLEXIS. RENFLEXIS ( infliximab-abda ) for injection, for intravenous use Initial Approval: 2017 RENFLEXIS ( infliximab-abda ) is biosimilar* to REMICADE (infliximab). (1) WARNING: SERIOUS INFECTIONS and MALIGNANCY See full prescribing information for complete boxed warning. Increased risk of serious infections leading to hospitalization or death, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis) and infections due to other opportunistic pathogens. Discontinue RENFLEXIS if a patient develops a serious infection.
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use RENFLEXIS safely and effectively. See full prescribing information …
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}